Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Israeli PM Netanyahu plans full military control of Gaza to eliminate Hamas and ensure national security, though not annexing or permanently governing the territory.
Krispy Kreme reports massive Q2 loss, triggering a turnaround plan focused on cost reduction and operational efficiency.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Israeli PM Netanyahu plans full military control of Gaza to eliminate Hamas and ensure national security, though not annexing or permanently governing the territory.
Krispy Kreme reports massive Q2 loss, triggering a turnaround plan focused on cost reduction and operational efficiency.